Collectively, these results along with the in vivo anti–PC9-GR tumor performance confirmed that HA-BPY-GEF-NPs + laser treatment could overcome GEF resistance by not only suppressing the EGFR signaling pathway but also down-regulating IGF1R and its downstream signal pathways through the generation of ROS. Here, EGFR is linked to neoplasm.